Skip to main content

Table 1 Demographic and clinical characteristics of the study participants. Participants were recruited at the movement disorders clinic at Karolinska University Clinic, Huddinge, Sweden. Patients underwent a clinical examination as described in the Methods section

From: Ecto-GPR37: a potential biomarker for Parkinson’s disease

 

NC

PD

Age (years)

64 ± 12

64 ± 11

Sex (M/F)

27/18

23/18

Disease duration (years)

5.8 ± 5.5

UPDRS Total (n = 26)

42 ± 18

UPDRS III (n = 26)

26 ± 14

H&Y score (n = 40)

II

MoCA (n = 28)

23 ± 5

HADS (n = 26)

14 ± 8

LED (n = 28)

709 ± 512

  1. Data are expressed as mean ± SD except the Hoehn and Yahr (H&Y) score as median. UPDRS Unified Parkinson’s Disease Scale; MoCA Montreal Cognitive Assessment scores; HADS Hospital Anxiety and Depression scale; LED L-dopa equivalent dose